Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sanger Sequencing01:57

Sanger Sequencing

773.0K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
773.0K
Next-generation Sequencing03:00

Next-generation Sequencing

97.6K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.6K
RNA-seq03:21

RNA-seq

11.7K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
11.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

From curiosity to clinical relevance: Rethinking genetic mosaicism.

Journal of the American Association of Nurse Practitioners·2026
Same author

Recognizing repeat expansion disorders in clinical practice.

Journal of the American Association of Nurse Practitioners·2026
Same author

Understanding mosaicism: A primer for clinicians.

Journal of the American Association of Nurse Practitioners·2026
Same author

Inherited thrombophilias: Genetics and testing considerations.

Journal of the American Association of Nurse Practitioners·2026
Same journal

A low-cost approach to national surveys of the nurse practitioner workforce in a resource-constrained environment.

Journal of the American Association of Nurse Practitioners·2026
Same journal

Drug pricing policy and its impact on clinical practice.

Journal of the American Association of Nurse Practitioners·2026
Same journal

Preclinical objective structured clinical examination for Family Nurse Practitioner students: Impact on clinical confidence and perceptions of curricular integration.

Journal of the American Association of Nurse Practitioners·2026
Same journal

Under fire: Federal policy shifts and the impact on gender minority college students.

Journal of the American Association of Nurse Practitioners·2026
Same journal

Metastatic pleural mesothelioma presenting as ulcerated submucosal colonic nodules.

Journal of the American Association of Nurse Practitioners·2026
See all related articles

Related Experiment Video

Updated: Jan 12, 2026

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

9.8K

DNA sequencing in newborn screening.

Mindy B Tinkle1

  • 1University of New Mexico College of Nursing, Albuquerque, New Mexico.

Journal of the American Association of Nurse Practitioners
|November 6, 2025
PubMed
Summary
This summary is machine-generated.

Genome sequencing offers expanded newborn screening capabilities for early detection of more conditions. Challenges in infrastructure, cost, and ethics must be addressed for widespread adoption of this public health advancement.

More Related Videos

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.5K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.0K

Related Experiment Videos

Last Updated: Jan 12, 2026

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

9.8K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.5K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.0K

Area of Science:

  • Genomics and Public Health
  • Neonatal Medicine
  • Healthcare Systems Modernization

Background:

  • The current newborn screening system faces capacity limitations and requires modernization.
  • Genomic-based screening presents an opportunity to identify a broader range of conditions, including those without existing biomarkers.
  • Emerging transformative treatments necessitate enhanced diagnostic capabilities for newborns.

Purpose of the Study:

  • To explore the potential of genome sequencing as a screening tool for newborn screening.
  • To identify challenges and opportunities associated with large-scale implementation of genomic screening in newborns.
  • To inform the evolution of newborn screening practices through stakeholder engagement.

Main Methods:

  • Review of pilot studies and national initiatives focused on genome sequencing in newborn screening.
  • Analysis of data on feasibility, acceptability, and health, behavioral, and economic outcomes.
  • Consideration of infrastructure, cost, workforce, scientific, technical, coordination, privacy, ethical, legal, and leadership issues.

Main Results:

  • Genome sequencing shows promise for identifying more conditions in newborns, particularly those lacking biomarkers.
  • Significant challenges exist for large-scale implementation, including infrastructure development, cost, workforce, and ethical considerations.
  • International and domestic initiatives are generating valuable data on the feasibility and outcomes of genomic newborn screening.

Conclusions:

  • Genome sequencing holds transformative potential for newborn screening, expanding the scope of early disease detection.
  • Addressing multifaceted challenges is crucial for the successful integration of genome sequencing into public health newborn screening programs.
  • Continuous evolution of practices, informed by ongoing research and stakeholder participation, is essential for advancing newborn screening.